Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

Authors :: Gonzalez-Alvaro, I.
Ortiz, A.M.
Dominguez-Jimenez, C.
Aragon-Bodi, A.
Diaz Sanchez, B.
Sanchez-Madrid, F.
Source :: Annals of the Rheumatic Diseases. Oct, 2009, Vol. 68 Issue 10, p1644, 7 p.
Publication Year :: 2009

Subjects :: Tumor necrosis factor -- Physiological aspects
Tumor necrosis factor -- Research
Leflunomide -- Dosage and administration
Leflunomide -- Research
Interleukins -- Physiological aspects
Interleukins -- Research
Rheumatoid arthritis -- Development and progression
Rheumatoid arthritis -- Research
Cellular signal transduction -- Research
Health

Tools